Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer

PURPOSE: Radiation therapy (RT) and hormone receptor (HR) inhibition are used for the treatment of HR-positive breast cancers; however, little is known about the interaction of the androgen receptor (AR) and estrogen receptor (ER) in response to RT in AR-positive, ER-positive (AR+/ER+) breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Michmerhuizen, Anna R., Lerner, Lynn M., Ward, Connor, Pesch, Andrea M., Zhang, Amanda, Schwartz, Rachel, Wilder-Romans, Kari, Eisner, Joel R., Rae, James M., Pierce, Lori J., Speers, Corey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427858/
https://www.ncbi.nlm.nih.gov/pubmed/35618789
http://dx.doi.org/10.1038/s41416-022-01849-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427858/
https://www.ncbi.nlm.nih.gov/pubmed/35618789
http://dx.doi.org/10.1038/s41416-022-01849-9

Ejemplares similares